Ex-Pfizer SVP named CEO of BioClinica

BioClinica has named John Hubbard as its new CEO. Hubbard joins the company from Pfizer ($PFE), where he worked as senior vice president and worldwide head of development operations. The move sees Hubbard step back into the vendor and service provider sector, a field with which he is familiar. Prior to joining Pfizer, Hubbard headed up clinical research services at Icon ($ICLR). Release

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.